NEWTON PLACE SURGERY
NEWTON ROAD, FAVERSHAM
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 32 | 37 | 86.5% | |
| HF 4 | 2011 | 35 | 40 | 87.5% | |
| HF 4 | 2012 | 31 | 35 | 88.6% | |
| HF 4 | 2013 | 36 | 41 | 87.8% | |
| HF004 | 2014 | 27 | 30 | 90.0% | |
| HF004 | 2015 | 22 | 23 | 95.7% | |
| HF004 | 2016 | 16 | 17 | 94.1% | |
| HF004 | 2017 | 17 | 18 | 94.4% | |
| HF004 | 2018 | 15 | 16 | 93.8% | |
| HF004 | 2019 | 41 | 47 | 87.2% | |
| HF004 | 2020 | 36 | 39 | 92.3% | |
| HF006 | 2021 | 103 | 117 | 88.0% | |
| HF006 | 2022 | 116 | 128 | 90.6% | |
| HF006 | 2023 | 121 | 138 | 87.7% |
